On Demand | Masterclass on Tumor Biomarkers

Τα πιστοποιητικά είναι διαθέσιμα!
Δεν υπάρχουν διαθέσιμα δεδομένα. Επικοινωνήστε μαζί μας μέσω email ζητώντας την πιστοποίησή σας ή καλέστε μας για να σας βοηθήσουμε.


F. Koinis


Chairs: F. Koinis, A. Roussidis


Precision Medicine: The hope to improve better clinical outcomes in daily clinical oncology E.Papadopoulou

Chairs: G. Nasioulas, D.Hatzibougias


09.30-09.50 Τhe emerged importance of pathologist  beyond the diagnostic workup

P. Foukas


09.50-10.10 How big polygenic panels do we need for tumor molecular profiling?

N. Pisimisis


10.10-10.30 RNA sequence: Could be emerged as a new tool for personalized treatment in cancer?

Ef. Kosmidis


10.30-10.50 HRD score: A new biomarker for PARP inhibitors

P. Konstantoulakis 


10.50-11.10 Advancing cancer care with Comprehensive Genomic Profiling (CGP)

A. Grybos-Gajniak

sponsored by bioanalytica


11.10-11.20 Discussion


Chairs: V. Georgoulias, P. Foukas


The importance of Liquid Biopsy as a tool for the understanding of the natural history and the metastatic process

E. Lianidou

Chairs: A. Markou, E. Galani


12.10-12.30 The phenotypic heterogeneity of Circulating Tumor Cells in breast cancer

G. Kallergi


12.30-12.50 The molecular heterogeneity of Circulating Tumor Cells in breast cancer

A. Strati


12.50-13.10 ESR1 mutation as a marker for hormone resistance treatment in breast cancer

D. Stergiopoulou


13.10-13.20 Discussion


Chairs: I. Kotteas, N. Spanakis


13.20-13.40 Clinical applications of Circulating Tumor Cells in breast cancer

A. Markou


13.40-14.00 Clinical applications of ctDNA in breast cancer

E. Karatrasoglou


14.00-14.10 Discussion


Chairs: A. Strati, E. Kontopodis


15.00-15.20 The clinical relevance of CTC in prostate cancer

Α. Strati

15.20-15.40 The emerging importance of CTC in NSCLC

A. Ntzifa 

15.40-16.00 the exosomes as a potential tool of tumor biomarkers

A. Xagara 

16.00-16.10 Discussion


Chairs: G. Nasioulas, D. Ziogas

16.10-16.30 Newer biomarkers in NSCLC (EGFR exon 20 mut, KRAS mut, MET exon 14 mut)

D. Stefanou 

16.30-16.50 Newer biomarkers in NSCLC (NTRK, RET, HER2 mut)

Th. Tegos 


16.50-17.10 Germ line mutations of DNA Damage Repair (DDR) genes as therapeutic tumor biomarkers: Where do we stand?

O. Fiste

17.10-17.20 Discussion


Chairs: Ch. Kosmas, V. Georgoulias


17.50-18.10 Clinical applications of liquid biopsy in NSCLC

F. Papageorgiou

18.10-18.30 Monitoring of ctDNA for treatment efficacy in colorectal cancer patients

I. Samaras 

18.30-18.50 Monitoring the Minimal Residual Disease using liquid Biopsy assays

A. Voutsina 

18.50-19.10 The Signatera R platform for the detection of MRD

N. Tsoulos 

19.10-19.20 Discussion

Chairs: P. Konstantoulakis, K. Tsigaridas


08.20-08.40 Emerging molecular subgroups in Colorectal cancers using NGS technology


08.40-09.00 Biomarkers in pancreatic and biliary tract carcinomas

D. Symeonidis

09.00-09.20 The NTRK fusions as a biomarker for personalized treatment

A. Kyriazoglou

Chairs: A. Karampeazis, E. Patsea

09.20-09.40 The prognostic and predictive value of TILs

I. Pateras

09.40-10.00 Is PD-L1 a real biomarker for treatment with ICIs?

I. Vamvakaris

10.00-10.20 Tumor Mutation Burden (TMB): When and How

G. Tsaousis 

10.20-10.40 Intergrading MSI/MMR testing in the daily clinical practice

Α. Assi

Chairs: A. Kotsakis, F. Koinis

The emergence of Tissue-Agnostic treatment in clinical oncology

M. Rovithi

Assi A.
Medical Oncologist and Clinical Research Fellow, Henry Dunant Hospital Center and Attikon University Hospital
Fiste O.
Fellow in Medical Oncology, Medical Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Foukas P.
MD, Associate Professor, 2nd Department of Pathology, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece
Galani E.
MD, Professor of Oncology and Sandr a J. Schulze Professor of Nov el Therapeutics, Executive Dean of Development, Mayo Clinic, Rochester, Minnesota, USA - Chair, Neuro-Oncology Committee, Alliance for Clinical Trials in Oncology
Grybos-Gajniak A.
Senior Clinical Sales Specialist, Europe
Hatzibougias D.
MD, MSc, PhD, Pathologist, CEO, microDiagnostics S.A.
Kallergi G.
Assistant Professor of Biochemistry, Department of Biology, University of Patras, Greece
Karampeazis Α.
MD, MSc, PhD, Director, Medical Oncology Unit, NIMTS, (Veterans Hospital), Athens
Karatrasoglou E.
MD, MSc, PhD, Medical Oncology Resident Doctor
Koinis F.
MD, PhD, Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
Konstantoulakis P.
PhD, Molecular Biologist - Geneticist, Scientific Director of Genotypos M.S.A., Athens
Kontopodis E.
MD, Medical Oncologist, Attending Physician, Venizeleion General Hospital of Heraklion
Kosmas Ch.
MD, Consultant & Head: Department of Medical Oncology & Hematopoietic Cell Transplant Unit, “Metaxa” Cancer Hospital, Piraeus, Greece
Kosmidis E.
Associate Professor, Laboratory of Physiology, Department of Medicine, Aristotle University of Thessaloniki, Greece
Kotsakis A.
MD, PhD, Associate Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larisa, Thessaly, Greece
Kotteas Ε.
Associate Professor of Oncology, National & Kapodistrian University of Athens
Kyriazoglou A
MD, PhD, Medical Oncologist, National & Kapodistrian University of Athens, 2nd Propaedeutic Department of Medicine, Attikon University Hospital, Athens, Greece
Lianidou E.
Professor of Analytical Chemistry - Clinical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept of Chemistry, University of Athens, Athens, Greece
Markou A.
PhD, Assistant Professor, Lab of Analysis Circulating Tumor Cells (ACTC), Lab of Analytical Chemistry, Dept of Chemistry, National and Kapodistrian University of Athens, Greece
Nasioulas G.
PhD, Chief Scientific Officer, Genekor Medical S.A., Athens, Greece
Ntzifa A.
PhD Candidate, Analysis of Circulating Tumor Cells Lab, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece
Papadopoulou E.
PhD, Group Leader of Molecular Oncology, Genekor Medical S.A., Athens, Greece
Papageorgiou F.
PhD, Molecular Biologist, Diagnostics Lead Oncology, AstraZeneca, Greece
Pateras I.
Bsc, MD, PhD, Pathologist, Assistant Professor, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Patsea E.
MD, Pathologist, Head of Department, Metropolitan General Hospital, Athens, Greece
Pisimisis N.
BSc, PhD, Head of Molecular Oncology Dept, AlfaLab Private Diagnostic Laboratory, Member of HHG, Athens
Roussidis A.
Country Medical Director, Gsk, Athens
Rovithi M.
Medical Oncologist, Agios Nikolaos General Hospital, Crete, Greece
Samaras I.
MD, Medical Oncologist, University Hospital of Larissa, Greece
Spanakis N.
PhD, Associate. Professor of Microbiology, General Manager, AlfaLab Private Diagnostic Laboratory, Member of HHG, Athens
Stefanou D.
MD, PhD, Mesical Oncologist, 1rst Department of Internal Medicine, Laiko General Hospital, Athens, Greece
Stergiopoulou D.
MSc, Analysis of Circulating Tumor Cells Lab (ACTC Lab), Department of Chemistry, National and Kapodistrian University of Athens (NKUA)
Strati A.
Postdoctoral Researcher, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece
Symeonidis D.
MD, MSC, PhD, Oncologist - P athologist, Metropolitan General Hospital
Tegos Th.
Medical Oncologist, PhD, Evangelismos General Hospital, Athens, Greece
Tsaousis G.
PhD, Group Leader of Bioinformatics, Genekor Medical S.A., Athens, Greece
Tsigaridas K.
Consultant Oncologist, 1st Oncology Department, “Metropolitan” Hospital, Athens, Greece
Tsoulos N.
Chief Executive Officer, Genekor MSA
Tzardi M.
Professor of Pathology, Medical School, Univercity of Crete, Greece
Vamvakaris I.
MD, MSc, PhD, Pathologist,Head of Sotiria Pathology Department, Athens, Greece
Voutsina A.
MSc, PhD, Postdoctoral Researcher, Greek Genome Center, Biomedical Research, Foundation Academy of Athens (BRFAA), Athens, Greece
Xagara Α.
Molecular Biologist, PhD, Laboratory of Oncology, University of Thessaly, Larissa
Ziogas D.
MD, PhD, Academic Scholar in Medical Oncology 1st Department of Internal Medicine, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details